ArticleCell death discovery2025

TMEM45A enhances palbociclib resistance and cellular glycolysis by activating AKT/mTOR signaling pathway in HR+ breast cancer.

Cui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.